848 completed, 503 unknown, 434 recruiting, 188 terminated. 875 Phase 2, 463 Phase 1, 429 Not applicable, 195 Phase 3, 30 Phase 4.
Follow Esophageal Neoplasms: new trials by email Literature Review of Esophageal Neoplasms trials Research Report on Esophageal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Neoadjuvant Therapy for Esophageal Cancer Neoadjuvant concurrent chemoradiotherapy - Esophageal Carcinoma, Neoadjuvant Therapy | Not applicable | Enrolling by invitation | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | 43 | 2028-03-01 | 2025-05-25 |
| Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer Stereotactic body radiation treatment (SBRT) - Esophageal Cancer | Phase 2 | Not yet recruiting | AHS Cancer Control Alberta | 22 | 2027-03-01 | 2026-10-28 |
| ALDH2 Genetic Testing in East Asian Community Genetic Test Results Return, Alcohol Flushing Education - Healthy Adult, Flushing | Not applicable | Not yet recruiting | Northwestern University | 100 | 2027-02-01 | 2026-10-28 |
| RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel), Simvastatin, Durvalumab - Gastroesophageal Adenocarcinoma | Phase 2 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 184 | 2027-01-01 | 2026-07-10 |
| Outside the Cage (OTC) Robotic Esophagectomy OTC MIE Esophagectomy - Esophageal Cancer | Phase 1 | Not yet recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 31 | 2027-01-01 | 2026-03-18 |
| PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC Toripalimab, Carboplatin + Paclitaxel - Esophageal Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | Vanderbilt-Ingram Cancer Center | 20 | 2026-12-31 | 2026-09-23 |
| Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma Tislelizumab - Esophageal Cancer | Phase 3 | Not yet recruiting | Asan Medical Center | 172 | 2026-12-31 | 2026-10-29 |
| A Randomized, Controlled, Double-Blind, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Enlonstobart, With or Without SYS6010 as Adjuvant Therapy, in Participants With Pathologically Residual Esophageal Squamous Cell Carcinoma Following Complete Surgical Resection SYS6010, SG001, SG001 placebo-mimicking - Esophageal Squamous Cell Carcinoma | Phase 3 | Not yet recruiting | CSPC Megalith Biopharmaceutical Co.,Ltd. | 585 | 2026-12-30 | 2026-11-09 |
| A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation LG00313112 - Ovarian Cancer, Small Cell Lung Cancer | Phase 1 / Phase 2 | Not yet recruiting | LG Chem | 250 | 2026-12-01 | 2026-08-07 |
| Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA Zanidatamab - Esophageal Cancer, GastroEsophageal Cancer | Not yet recruiting | Jazz Pharmaceuticals | 300 | 2026-11-30 | 2026-10-26 | |
| Effect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High Risk for Obstructive Sleep Apnea Syndrome in High-altitude Regions High-flow nasal cannula Group, Regular Nasal Cannula Group - Hypoxemia, Gastric Cancer (Diagnosis) | Not applicable | Not yet recruiting | Diansan Su | 430 | 2026-11-02 | 2026-10-29 |
| Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer Enteral or parenteral nutrition - Esophageal Cancer, Surgery Indication | Recruiting | University Hospital, Bordeaux | 670 | 2026-11-01 | 2026-05-13 | |
| Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma Standardized Management Protocol for Esophageal Fistula - Esophageal Squamous Cell Carcinoma (ESCC), Esophageal Fistula | Not yet recruiting | Peking University Cancer Hospital & Institute | 32 | 2026-11-01 | 2026-11-05 | |
| Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function Larotinib - Esophageal Cancer, Advanced Solid Tumor | Phase 1 | Withdrawn | Sunshine Lake Pharma Co., Ltd. | 2026-10-30 | 2026-09-28 | |
| A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. PF-08098488 - Pancreatic Ductal Adenocarcinoma, Esophageal Cancer | Phase 1 | Recruiting | Pfizer | 280 | 2026-10-29 | 2026-11-03 |
| Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) - Esophageal Adenocarcinoma | Phase 2 | Recruiting | Duke University | 60 | 2026-10-21 | 2026-11-04 |
| CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors CR-002 - Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ | Phase 1 / Phase 2 | Recruiting | Crescent Biopharma, Inc. | 219 | 2026-10-21 | 2026-11-02 |
| Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic STRO-006, Pembrolizumab - Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer | Phase 1 | Recruiting | Sutro Biopharma, Inc. | 285 | 2026-10-19 | 2026-10-23 |
| Modular Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer Modular Robot-Assisted Esophagectomy, Conventional Minimally Invasive Esophagectomy - Esophageal Cancer | Phase 3 | Recruiting | Ruijin Hospital | 160 | 2026-10-15 | 2026-10-22 |
| A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma) anlotinib + PD-1 inhibitor, PD-1 inhibitor - Esophageal Cancer (EC) | Phase 2 | Recruiting | Sun Yat-sen University | 112 | 2026-10-12 | 2026-10-07 |
Showing 20 of 2318. Sign in to see all of them.
Esophageal Squamous Cell Carcinoma (626) · Stomach Neoplasms (574) · Pancreatic Neoplasms (248) · Carcinoma, Non-Small-Cell Lung (227) · Adenocarcinoma Of Esophagus (205) · Lung Neoplasms (204) · Colorectal Neoplasms (201) · Breast Neoplasms (177) · Ovarian Neoplasms (161) · Neoplasms (149) · Head and Neck Neoplasms (141) · Uterine Cervical Neoplasms (141) · Colonic Neoplasms (125) · Urinary Bladder Neoplasms (123)
Digestive System Diseases (2310) · Neoplasms by Site (2310) · Digestive System Neoplasms (2306) · Gastrointestinal Diseases (2306) · Esophageal Diseases (2298) · Gastrointestinal Neoplasms (2259) · Head and Neck Neoplasms (2177) · Neoplasms (2169) · Neoplasms by Histologic Type (968) · Neoplasms, Glandular and Epithelial (915) · Carcinoma (862) · Carcinoma, Squamous Cell (680) · Neoplasms, Squamous Cell (651) · Stomach Diseases (576)
Cisplatin (238) · Paclitaxel (181) · Radiotherapy (174) · Fluorouracil (165) · Carboplatin (110) · Oxaliplatin (100) · pembrolizumab (91) · Docetaxel (86) · Irinotecan (78) · Drug Therapy (72) · Capecitabine (70) · Leucovorin (64) · Radiation (61) · Esophagectomy (58) · Surgical Procedures, Operative (51)
Fudan University (54) · National Cancer Institute (NCI) (48) · Sun Yat-sen University (47) · Memorial Sloan Kettering Cancer Center (41) · Tianjin Medical University Cancer Institute and Hospital (33) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (29) · M.D. Anderson Cancer Center (29) · National Taiwan University Hospital (28) · Chinese Academy of Medical Sciences (27) · Alliance for Clinical Trials in Oncology (22) · Shanghai Chest Hospital (22) · Henan Cancer Hospital (21) · Zhejiang Cancer Hospital (21) · Peking University (20) · Shanghai Zhongshan Hospital (20)
China (797) · United States (743) · United Kingdom (131) · France (123) · Taiwan (107) · Germany (99) · Netherlands (97) · South Korea (95) · Canada (91) · Japan (85) · Spain (82) · Italy (68) · Belgium (58) · Australia (52) · Denmark (39)
David H. Ilson, MD, PhD (11) · Aminah Jatoi, MD (8) · David S Schrump, M.D. (8) · Feng Wang (7) · Lin Shen, MD (7) · Yelena Janjigian, MD (7) · Peter Enzinger, MD (6) · Zefen Xiao, MD (6)
PMID 33538338, PMID 22646630, PMID 26808342, PMID 36990609, PMID 26254683, PMID 30089078, PMID 18309943, PMID 21684205, PMID 26313683, PMID 33373868, PMID 34454674, PMID 35623069, PMID 41309527, PMID 10235156, PMID 11208820, PMID 11870157, PMID 19465425, PMID 21839994, PMID 23148692, PMID 24224128, PMID 24371038, PMID 24612702, PMID 24982463, PMID 25668428, PMID 25691612, PMID 26805559, PMID 27223606, PMID 27266524, PMID 27742014, PMID 28742685, PMID 29799976, PMID 30207593, PMID 30291834, PMID 30308612, PMID 32768158, PMID 33026938, PMID 33553366, PMID 33674602, PMID 33813524, PMID 34160577, PMID 34351356, PMID 35440464, PMID 36812121, PMID 37139963, PMID 37195667, PMID 37488287, PMID 37496366, PMID 37932848, PMID 38710003, PMID 39221992
2023 (21), 2019 (11), 2017 (9), 2014 (5), 2015 (5), 2018 (5), P30CA008748 (5), P30CA043703 (5), P30CA068485 (5), U10CA032102 (5), 2016 (4), 2025 (4), U10CA021115 (4), P30CA015083 (3), P30CA016056 (3)